Surveillance mammography for older breast cancer survivors remains a gray area in medicine because regular screenings do not appear to reduce the risk of second primary breast cancers in older patients.
Why do older survivors still get annual mammograms?
“Because of this, the default is annual mammography like we do in younger women.”
They were no less common among women who kept up annual mammography than those who were screened less often.
What are the actual benefits and harms?
Generally, mammography is associated with about a 20% reduction in breast cancer mortality. Older adults don’t always have that time and may have other, more threatening medical issues.
The new JAMA Internal Medicine study only captured new breast cancers, not recurrences.
Walter said that a mammogram is not just a flu shot. In all, 42% of the women had pain or psychological distress as a result of screening.
The focus should have been on their current illnesses and how to help them live better, she added.
Which guidelines do providers actually use?
There are various guidelines on surveillance mammography. The American Cancer Society recommends annual surveillance mammograms.
Neither guideline includes life-expectancy language.
Most PCPs use the US Preventive Services Task Force guidelines, Nekhlyudov said, though they are indicated for the general population, not necessarily those with a history of cancer. These suggest insufficient evidence for screening after age 75 and shared decision-making.
How do doctors decide what matters most?
Walter explained that the most important thing determining whether someone gets benefit or harm from an intervention is how sick they are and if they have other medical conditions.
Walter frames life expectancy as a tool for figuring out what matters most for any given patient.
Most PCPs already know which patients have comorbidities that limit life expectancy. Tools such as ePrognosis and DecideTogether.info can also be utilized. For patients with less than 10 years’ life expectancy, communication is key, and Schonberg supports shared decision-making in this controversial area.
Nekhlyudov emphasized that quality care and proper follow-up require close coordination between primary care and oncology. Patient preference also matters in the decision-making process.
“If a woman wants to continue screening, she absolutely can and should,” Freedman said. “I just hope there is a discussion…rather than the knee-jerk reflex to just continue.”
Ultimately, where data is lacking, the decision to continue surveillance mammograms is not a simple algorithm. Walter noted it remains the art of medicine and really thinking about the person in front of you.